Clinical presentation and management of moxidectin toxicity in two dogs.

This research paper explores the effects of moxidectin poisoning in two dogs and outlines the appropriate treatment methods. The study found that common medication used to treat poisoning was ineffective due to the nature of the toxicity. The authors recommend using anaesthetic agents with a different mode of action for better results.

Clinical Presentation of Moxidectin Toxicity

In the study, moxidectin accidentally ingested by two dogs had a profound effect. The main symptoms observed were:

• Generalised tremors: This implies the dogs were shaking excessively, likely due to the disruption of their nerve function.
• Ataxia: This is a neurological sign manifesting as lack of muscle control or coordination of voluntary movements.

These symptoms are attributed to the neurotoxic effects of moxidectin, which enhances the effect of gamma-aminobutyric acid in mammals.

Ineffectiveness of Diazepam Treatment

Diazepam, commonly used to treat anxiety, seizures, and muscle spasms among other conditions, did not produce a good response in the dogs. This lack of response is due to the nature of moxidectin toxicity, which potentiates (increases) the effect of gamma-aminobutyric acid in the nervous system. Since diazepam enhances the effect of gamma-aminobutyric acid, using it in case of moxidectin toxicity might further compound the problem rather than alleviating the symptoms.

Recommended Treatment Approach

Given the poor response to diazepam, the researchers suggest an alternative approach to managing moxidectin toxicity in dogs. They recommend avoiding gamma-aminobutyric acid agonists, such as benzodiazepines and barbiturates. Instead, it would be better to use anaesthetic agents with a different mechanism of action, such as propofol, which work by inhibiting particular brain receptors and can help in managing the neurological manifestations seen in these dogs.

Prognosis of Moxidectin Toxicity

If managed correctly, dogs exposed to moxidectin-containing horse deworming medication seem to have an excellent prognosis. Correct identification of the cause of neurotoxicity, along with appropriate medical management, is critical for the recovery of these patients.